eXoZymes, Inc.
EXOZ
$9.68
$0.373.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.75M | 1.38M | 1.35M | 888.20K | 1.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.55M | 1.95M | 1.98M | 1.61M | 1.33M |
| Operating Income | -2.55M | -1.95M | -1.98M | -1.61M | -1.33M |
| Income Before Tax | -2.36M | -1.86M | -1.84M | -1.66M | -1.36M |
| Income Tax Expenses | -- | -- | -2.10K | -- | 2.10K |
| Earnings from Continuing Operations | -2.36M | -1.86M | -1.84M | -1.66M | -1.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.36M | -1.86M | -1.84M | -1.66M | -1.36M |
| EBIT | -2.55M | -1.95M | -1.98M | -1.61M | -1.33M |
| EBITDA | -2.48M | -1.88M | -1.92M | -1.54M | -1.26M |
| EPS Basic | -0.28 | -0.22 | -0.24 | -0.26 | -0.22 |
| Normalized Basic EPS | -0.18 | -0.14 | -0.15 | -0.17 | -0.14 |
| EPS Diluted | -0.28 | -0.22 | -0.24 | -0.26 | -0.22 |
| Normalized Diluted EPS | -0.18 | -0.14 | -0.15 | -0.17 | -0.14 |
| Average Basic Shares Outstanding | 8.38M | 8.37M | 7.50M | 6.25M | 6.25M |
| Average Diluted Shares Outstanding | 8.38M | 8.37M | 7.50M | 6.25M | 6.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |